A detailed history of Wealthcare Advisory Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 3,089 shares of VRTX stock, worth $1.55 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,089
Previous 3,328 7.18%
Holding current value
$1.55 Million
Previous $1.56 Million 7.89%
% of portfolio
0.04%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$460.0 - $505.78 $109,940 - $120,881
-239 Reduced 7.18%
3,089 $1.44 Million
Q2 2024

Aug 09, 2024

BUY
$392.81 - $485.53 $43,209 - $53,408
110 Added 3.42%
3,328 $1.56 Million
Q1 2024

Apr 15, 2024

BUY
$407.69 - $446.08 $57,484 - $62,897
141 Added 4.58%
3,218 $1.35 Million
Q4 2023

Feb 06, 2024

SELL
$343.0 - $410.68 $14,063 - $16,837
-41 Reduced 1.31%
3,077 $1.25 Million
Q3 2023

Oct 12, 2023

SELL
$338.18 - $362.46 $11,159 - $11,961
-33 Reduced 1.05%
3,118 $1.08 Million
Q2 2023

Jul 17, 2023

SELL
$314.42 - $351.91 $65,399 - $73,197
-208 Reduced 6.19%
3,151 $1.11 Million
Q1 2023

May 04, 2023

SELL
$283.23 - $323.1 $25,773 - $29,402
-91 Reduced 2.64%
3,359 $1.06 Million
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $26,004 - $29,254
91 Added 2.71%
3,450 $996,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $42,717 - $47,662
156 Added 4.87%
3,359 $973,000
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $66,023 - $82,206
-281 Reduced 8.07%
3,203 $903,000
Q1 2022

Apr 15, 2022

SELL
$221.42 - $260.97 $31,220 - $36,796
-141 Reduced 3.89%
3,484 $909,000
Q4 2021

Feb 11, 2022

BUY
$177.01 - $223.45 $386,766 - $488,238
2,185 Added 151.74%
3,625 $796,000
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $1,088 - $1,217
6 Added 0.42%
1,440 $261,000
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $6,187 - $7,296
33 Added 2.36%
1,434 $289,000
Q1 2021

Apr 30, 2021

BUY
$207.02 - $241.31 $290,035 - $338,075
1,401 New
1,401 $301,000
Q2 2020

Jul 29, 2020

SELL
$225.48 - $295.8 $24,126 - $31,650
-107 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$199.77 - $247.81 $799 - $991
4 Added 3.88%
107 $25,000
Q1 2018

May 15, 2018

SELL
$151.6 - $177.13 $454 - $531
-3 Reduced 2.83%
103 $17,000
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $411 - $466
3 Added 2.91%
106 $16,000
Q3 2017

Nov 15, 2017

BUY
$148.13 - $162.24 $15,257 - $16,710
103
103 $16,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.